Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're still feeling hungry on tirzepatide, you're not doing anything wrong. Appetite suppression with Mounjaro tends to build gradually over several weeks, and many people find the first pen or two feels underwhelming before the effect clicks in. This is a prescription-only medicine — a prescriber should know if hunger is persisting well into treatment, because the causes vary and the solutions differ.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and it catches a lot of people off guard. Tirzepatide works as a dual GIP and GLP-1 receptor agonist, it activates two gut-hormone pathways involved in appetite regulation and slows the rate at which food leaves the stomach. But those effects are dose-dependent. The starting dose of 2.5mg exists to let your body adjust, not to deliver maximum appetite suppression from day one.
Most people notice hunger reducing more meaningfully once they move up to 5mg or beyond. In the SURMOUNT-1 trial, significant weight changes accumulated over 72 weeks, not in the first fortnight. The NHS tirzepatide guidance notes that the therapeutic response builds with titration, so a quiet first pen is par for the course rather than a sign of failure.
If you find yourself watching the clock to your next meal in week two, that's a normal experience. If you want to understand more about why you might still feel hungry on tirzepatide, including what's typical and what isn't, the question that matters more is whether hunger is still your dominant feeling several months in, if so, keep reading.
Tirzepatide doesn't neutralise hunger on its own regardless of what you eat. Ultra-processed foods (particularly those engineered to be palatable regardless of fullness signals) can partly override the satiety cues the medicine is working to strengthen. High-sugar, low-fibre meals digest quickly and leave the stomach fast, shortening the window of fullness that slower gastric emptying is supposed to create.
Protein is the macronutrient most consistently associated with satiety, and it matters more on treatment than off it, because overall food volume drops and nutrient density becomes critical. The practical guide to eating on Mounjaro covers this in detail, but the short version: meals built around protein and fibre tend to extend the fullness effect you're trying to get from tirzepatide, while meals built around refined carbohydrates tend to shorten it.
Hydration is another overlooked factor. Thirst and mild hunger feel similar, and on a reduced appetite it's easy to eat less but also drink less, something our prescribers hear about regularly. A glass of water before meals is a small, evidence-consistent habit that adds up.
Sleep deprivation is one of the more significant appetite disruptors, and it operates independently of what tirzepatide is doing. Poor sleep raises ghrelin (the hunger hormone) and lowers leptin (the fullness signal), essentially working against the medicine's mechanism. This isn't a reason to panic, but if your sleep is consistently disrupted, addressing it is genuinely useful alongside treatment.
Stress has a similar physiological footprint. Cortisol promotes appetite, particularly for energy-dense food, and chronic stress can dampen the subjective experience of fullness even when the stomach is physically full. Neither sleep nor stress is something a higher dose alone fixes.
Some medications interact with appetite regulation too. If you've recently started or changed other prescribed medicines, it's worth flagging to your prescriber. The same applies if your hunger suddenly increased after a period of good appetite control, that kind of shift is worth investigating rather than just tolerating. You can read more about the reasons hunger persists on tirzepatide including how other medications can play a role.
For an honest look at what treatment costs and what's included, that information is available if you're comparing private options.
If you're on a stable dose and several months in and hunger is genuinely unchanged from before you started, that's the conversation to have. A prescriber can look at whether titration to a higher dose is appropriate, whether your food and lifestyle picture needs adjusting, or whether something else is contributing. Ongoing hunger on Mounjaro isn't always a dose problem, sometimes it's a meal-composition problem, sometimes a sleep or stress problem, sometimes a combination.
At nume, every repeat order is reviewed by a GPhC-registered prescriber before it's dispensed. That review is where questions like this belong, not in a forum, not left to guesswork. If hunger is your main concern right now, raising it through aftercare is exactly what it's there for. The frequently asked questions page covers common aftercare queries too.
If you haven't started treatment yet and you're researching what to expect, check your eligibility with a free consultation, our prescribers can walk you through what to expect at each stage.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.